mounjaro tirzepatide 10mg more effective in blood sugar control and weight loss than semaglutide, meta-analysis finds Mounjaro (Tirzepatide) is a type of medication called a dual glucose Mounjaro (Tirzepatide) Injection 10 mg/0.5

Originally derived from a protective protein found in human gastric juice, BPC157 (Body Protection Compound157) is gaining serious traction among athletes, bodybuilders, and biohackers for its potential to accelerate healing at the cellular level

Semaglutide is a GLP1 receptor agonist, originally developed for type 2 diabetes management

BPC 157 is on the WADA Prohibited List under category S0 Non-Approved Substances, it is also banned in the NFL but does not yet appear on the MLB banned substance list

This prolonged circulation time is a shared trait between both compounds, ensuring steady-state levels with weekly dosing